90 related articles for article (PubMed ID: 11697650)
1. A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors.
Honma Y
Leuk Lymphoma; 2001; 42(5):953-62. PubMed ID: 11697650
[TBL] [Abstract][Full Text] [Related]
2. Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Niitsu N; Yamaguchi Y; Umeda M; Honma Y
Blood; 1998 Nov; 92(9):3368-75. PubMed ID: 9787175
[TBL] [Abstract][Full Text] [Related]
3. Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
Niitsu N; Umeda M; Honma Y
Leuk Res; 2000 Jan; 24(1):1-9. PubMed ID: 10634639
[TBL] [Abstract][Full Text] [Related]
4. Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia.
Honma Y; Niitsu N
Leuk Lymphoma; 2000 Sep; 39(1-2):57-66. PubMed ID: 10975384
[TBL] [Abstract][Full Text] [Related]
5. Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells.
Niitsu N; Yamamoto-Yamaguchi Y; Kasukabe T; Okabe-Kado J; Umeda M; Honma Y
Blood; 2000 Aug; 96(4):1512-6. PubMed ID: 10942399
[TBL] [Abstract][Full Text] [Related]
6. Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
Niitsu N; Honma Y
Leuk Lymphoma; 1999 Jul; 34(3-4):261-71. PubMed ID: 10439363
[TBL] [Abstract][Full Text] [Related]
7. Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
Niitsu N; Umeda M; Honma Y
Biochem Biophys Res Commun; 1997 Sep; 238(1):100-6. PubMed ID: 9299460
[TBL] [Abstract][Full Text] [Related]
8. The combination of adenosine deaminase inhibition and deoxyadenosine induces apoptosis in a human astrocytoma cell line.
Garcia-Gil M; Tozzi MG; Varani S; Della Verde L; Petrotto E; Balestri F; Colombaioni L; Camici M
Neurochem Int; 2015 Jan; 80():14-22. PubMed ID: 25447764
[TBL] [Abstract][Full Text] [Related]
9. 2'-deoxyadenosine induces apoptosis in rat chromaffin cells.
Wakade AR; Guo X; Palmer KC; Kulkarni JS; Przywara DA; Wakade TD
J Neurochem; 1996 Dec; 67(6):2273-81. PubMed ID: 8931458
[TBL] [Abstract][Full Text] [Related]
10. Biochemical correlates of the differential sensitivity of subtypes of human leukemia to deoxyadenosine and deoxycoformycin.
Matsumoto SS; Yu AL; Bleeker LC; Bakay B; Kung FH; Nyhan WL
Blood; 1982 Nov; 60(5):1096-102. PubMed ID: 6289941
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
Matsumoto M; Weckbecker G; Cory JG
Cancer Commun; 1990; 2(1):1-6. PubMed ID: 2369548
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis in vivo and in vitro in hairy cell leukemia treated by deoxycoformycin.
Ogawa K; Shichishima T; Nakamura N; Maruyama Y
Tohoku J Exp Med; 2000 Sep; 192(1):87-98. PubMed ID: 11128872
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis in CD4+ prolymphocytic leukemia by deoxyadenosine and 2'-deoxycoformycin.
Johnston JB; Lee K; Verburg L; Blondal J; Mowat MR; Israels LG; Begleiter A
Leuk Res; 1992 Aug; 16(8):781-8. PubMed ID: 1528066
[TBL] [Abstract][Full Text] [Related]
14. Enhanced cytotoxicity and inhibition of DNA damage repair in irradiated murine L5178Y lymphoblasts and human chronic lymphocytic leukemia cells treated with 2'-deoxycoformycin and deoxyadenosine in vitro.
Begleiter A; Pugh L; Israels LG; Johnston JB
Cancer Res; 1988 Jul; 48(14):3981-6. PubMed ID: 3260129
[TBL] [Abstract][Full Text] [Related]
15. Deoxynucleoside induces neuronal apoptosis independent of neurotrophic factors.
Wakade AR; Przywara DA; Palmer KC; Kulkarni JS; Wakade TD
J Biol Chem; 1995 Jul; 270(30):17986-92. PubMed ID: 7629106
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia.
Kost SE; Bouchard ED; LaBossière É; Ye X; Queau ML; Liang WS; Banerji V; Gibson SB; Katyal S; Johnston JB
Leuk Res; 2016 Nov; 50():63-71. PubMed ID: 27683974
[TBL] [Abstract][Full Text] [Related]
17. Purine enzyme profile in human colon-carcinoma cell lines and differential sensitivity to deoxycoformycin and 2'-deoxyadenosine in combination.
Camici M; Turriani M; Tozzi MG; Turchi G; Cos J; Alemany C; Miralles A; Noe V; Ciudad CJ
Int J Cancer; 1995 Jul; 62(2):176-83. PubMed ID: 7622293
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of adenosine and deoxyadenosine by human erythrocytes and CCRF-CEM leukemia cells.
Szabados E; Duggleby RG; Christopherson RI
Int J Biochem Cell Biol; 1996 Dec; 28(12):1405-15. PubMed ID: 9022297
[TBL] [Abstract][Full Text] [Related]
19. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2'-deoxycoformycin in vivo and in vitro.
Begleiter A; Glazer RI; Israels LG; Pugh L; Johnston JB
Cancer Res; 1987 May; 47(9):2498-503. PubMed ID: 3494509
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with nucleoside analogs and alkylating agents.
Johnston JB; Verburg L; Shore T; Williams M; Israels LG; Begleiter A
Leukemia; 1994 Apr; 8 Suppl 1():S140-3. PubMed ID: 8152282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
